Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

DNA Sequencing Market Size, Share, Trends, and Forecast, 2026-2033 | Market to Reach $91.9 Billion as Next-Generation Sequencing Expands Oncology and Rare Disease Diagnostics

globenewswire.com
TMO Thermo Fisher Scientific is positioned to benefit from the expanding DNA sequencing market, driven by increased adoption in oncology and rare disease diagnostics, and sustained investment in genomics research. A Agilent Technology is poised to gain from the growth in the DNA sequencing market, fueled by expanding applications in diagnostics and research, and increasing investments in genomics. ILMN Illumina is a key player in the DNA sequencing market, which is projected for significant growth. The company's technologies are central to the expansion of next-generation sequencing, driving demand in diagnostics and research. QGEN QIAGEN is expected to benefit from the expanding DNA sequencing market, particularly with the growth in oncology and rare disease diagnostics, and the overall increase in genomics research investment. ONT Oxford Nanopore Technologies is a significant player in the DNA sequencing market, with its technologies contributing to the growth driven by expanding applications in diagnostics and research. PACB PacBio is positioned to benefit from the significant growth projected for the DNA sequencing market, driven by advancements in technology and expanding applications in diagnostics and research. MYGN Myriad Genetics is well-positioned to benefit from the expanding DNA sequencing market, especially with its focus on oncology and rare disease diagnostics, which are key growth drivers.

DNA Sequencing Market Size, Share, Trends, and Forecast, 2026-2033 | Market to Reach $91.9 Billion as Next-Generation Sequencing Expands Oncology and Rare Disease Diagnostics Dublin, Sept. 29, 2026 (GLOBE NEWSWIRE) -- "DNA Sequencing Market Size, Share & Trends Analysis Report by Product & Service, Technology, Workflow, Application, End-use, and Segment Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

The global DNA sequencing market size was valued at USD 17.9 billion in 2025 and is projected to increase from USD 21.7 billion in 2026 to USD 91.9 billion by 2033. The market is expected to grow at a CAGR of 22.9% from 2026 to 2033, supported by the expanding adoption of next generation sequencing technologies, broader clinical use in oncology and rare disease diagnostics, and sustained investment in genomics research.

North America accounted for the largest regional share in 2025, representing 51.1% of the global DNA sequencing market. The region's leading position reflects its established genomics research infrastructure, strong clinical adoption of sequencing technologies, and continued activity among academic institutions, healthcare providers, and pharmaceutical and biotechnology companies.

DNA sequencing is becoming increasingly important across research, clinical investigation, reproductive health, drug development, agrigenomics, forensics, epidemiology, and consumer genomics. Growing demand for sequencing instruments, consumables, analytical capabilities, and specialized services is contributing to market expansion. At the same time, advancements across pre-sequencing, sequencing, and data analysis workflows are supporting the efficient processing and interpretation of genomic information.

Global DNA Sequencing Market Report Scope

The report analyzes revenue growth and key market trends across DNA sequencing industry sub-segments from 2021 to 2033. The market assessment covers product and services, technology, workflow, application, end-use, and region, providing insight into the areas expected to influence global industry development throughout the forecast period.

Product & Service Outlook (Revenue, USD Million, 2021-2033)

Demand across these categories is linked to the continued expansion of sequencing capacity in research and clinical environments. Consumables support recurring laboratory requirements, while instruments and services enable organizations to establish, scale, or outsource sequencing operations.

Technology Outlook (Revenue, USD Million, 2021-2033)

Technology adoption is being shaped by the requirements of diverse research and diagnostic applications. Next-Generation Sequencing remains a central growth driver as laboratories seek scalable genomic analysis, while Sanger Sequencing and Third Generation Sequencing continue to serve distinct analytical and research needs.

Workflow Outlook (Revenue, USD Million, 2021-2033)

Each workflow stage contributes to the overall DNA sequencing market, from sample preparation and sequencing procedures to genomic data processing and interpretation. Increasing sequencing volumes are also strengthening the importance of reliable data analysis capabilities.

Application Outlook (Revenue, USD Million, 2021-2033)

Oncology and clinical investigation are prominent areas of sequencing adoption, supported by growing interest in genomic profiling and rare disease diagnostics. Additional opportunities are emerging across reproductive health, immune system monitoring, metagenomics, epidemiology, and pharmaceutical research.

End Use Outlook (Revenue, USD Million, 2021-2033)

The expanding end-use base demonstrates the increasing integration of DNA sequencing into healthcare, life sciences research, and therapeutic development. Academic and clinical organizations remain important contributors, while hospitals, clinics, and commercial life sciences companies are supporting broader market adoption.

Regional Outlook (Revenue, USD Million, 2021-2033)

The regional analysis evaluates market performance and revenue opportunities across major global economies. While North America led the market in 2025, continued genomics investment and expanding sequencing applications across Europe, Asia Pacific, Latin America, and MEA are expected to support the global DNA sequencing market through 2033.

Key Topics Covered:

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope

1.2. Market Definitions

1.2.1. Information Analysis

1.2.2. Market Formulation & Data Visualization

1.2.3. Data Validation & Publishing

1.3. Information Procurement

1.3.1. Primary Research

1.4. Information or Data Analysis

1.5. Market Formulation & Validation

1.6. Market Model

1.7. Objectives

1.7.1. Objective 1

1.7.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables and Trends

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Related/Ancillary Market Outlook

3.2. Market Trends and Outlook

3.3. Market Drivers

3.3.1. Increasing Adoption of DNA Vaccines

3.3.2. Declining Cost of Genome Sequencing

3.4. Market Restraint Analysis

3.4.1. Regulatory and Quality Compliance Challenges

3.5. Business Environment Analysis

3.5.1. PESTEL Analysis

3.5.2. Porter's Five Forces Analysis

Chapter 4. DNA Sequencing Market: Product & Service Estimates & Trend Analysis

4.1. Global DNA Sequencing Market: Product & Service Movement Analysis

4.2. Consumables

4.2.1. Consumables Market Estimates and Forecasts, 2021 to 2033 (USD Million)

4.3. Instruments

4.3.1. Instruments Market Estimates and Forecasts, 2021 to 2033 (USD Million)

4.4. Services

4.4.1. Services Market Estimates and Forecasts, 2021 to 2033 (USD Million)

Chapter 5. DNA Sequencing Market: Technology Estimates & Trend Analysis

5.1. Global DNA Sequencing Market: Technology Movement Analysis

5.2. Sanger Sequencing

5.2.1. Sanger Sequencing Market Estimates and Forecasts, 2021 to 2033 (USD Million)

5.3. Next-generation Sequencing (NGS)

5.3.1. Next-generation Sequencing (NGS) Market Estimates and Forecasts, 2021 to 2033 (USD Million)

5.3.2. Whole Genome Sequencing (WGS)

5.3.2.1. Whole Genome Sequencing (WGS) Market Estimates and Forecasts, 2021 to 2033 (USD Million)

5.3.3. Whole Exome Sequencing (WES)

5.3.3.1. Whole Exome Sequencing (WES) Market Estimates and Forecasts, 2021 to 2033 (USD Million)

5.3.4. Targeted Sequencing & Resequencing

5.3.4.1. Targeted Sequencing & Resequencing Market Estimates and Forecasts, 2021 to 2033 (USD Million)

5.4. Third Generation DNA Sequencing

5.4.1. Third Generation DNA Sequencing Market Estimates and Forecasts, 2021 to 2033 (USD Million)

5.4.2. Single-molecule Real-time Sequencing (SMRT)

5.4.2.1. Single-molecule Real-time Sequencing (SMRT) Market Estimates and Forecasts, 2021 to 2033 (USD Million)

5.4.3. Nanopore Sequencing

5.4.3.1. Nanopore Sequencing Market Estimates and Forecasts, 2021 to 2033 (USD Million)

Chapter 6. DNA Sequencing Market: Workflow Estimates & Trend Analysis

6.1. Global DNA Sequencing Market: Workflow Movement Analysis

6.2. Pre-sequencing

6.2.1. Pre-sequencing Market Estimates and Forecasts, 2021 to 2033 (USD Million)

6.3. Sequencing

6.3.1. Sequencing Market Estimates and Forecasts, 2021 to 2033 (USD Million)

6.4. Data Analysis

6.4.1. Data Analysis Market Estimates and Forecasts, 2021 to 2033 (USD Million)

Chapter 7. DNA Sequencing Market: Application Estimates & Trend Analysis

7.1. Global DNA Sequencing Market: Application Movement Analysis

7.2. Oncology

7.2.1. Oncology Market Estimates and Forecasts, 2021 to 2033 (USD Million)

7.3. Reproductive Health

7.3.1. Reproductive Health Market Estimates and Forecasts, 2021 to 2033 (USD Million)

7.4. Clinical Investigation

7.4.1. Clinical Investigation Market Estimates and Forecasts, 2021 to 2033 (USD Million)

7.5. Agrigenomics & Forensics

7.5.1. Agrigenomics & Forensics Market Estimates and Forecasts, 2021 to 2033 (USD Million)

7.6. HLA Typing/Immune System Monitoring

7.6.1. HLA Typing/Immune System Monitoring Market Estimates and Forecasts, 2021 to 2033 (USD Million)

7.7. Metagenomics, Epidemiology, & Drug Development

7.7.1. Metagenomics, Epidemiology, & Drug Development Market Estimates and Forecasts, 2021 to 2033 (USD Million)

7.8. Consumer Genomics

7.8.1. Consumer Genomics Market Estimates and Forecasts, 2021 to 2033 (USD Million)

7.9. Others

7.9.1. Others Market Estimates and Forecasts, 2021 to 2033 (USD Million)

Chapter 8. DNA Sequencing Market: End-use Estimates & Trend Analysis

8.1. Global DNA Sequencing Market: End-use Movement Analysis

8.2. Academic Research

8.2.1. Academic Research Market Estimates and Forecasts, 2021 to 2033 (USD Million)

8.3. Clinical Research

8.3.1. Clinical Research Market Estimates and Forecasts, 2021 to 2033 (USD Million)

8.4. Hospitals & Clinics

8.4.1. Hospitals & Clinics Market Estimates and Forecasts, 2021 to 2033 (USD Million)

8.5. Pharmaceutical & Biotechnology Companies

8.5.1. Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 to 2033 (USD Million)

8.6. Others

8.6.1. Others Market Estimates and Forecasts, 2021 to 2033 (USD Million)

Chapter 9. Regional Business Analysis

9.1. Global DNA Sequencing Market Share by Region, 2025 & 2033

9.2. Country-level Analysis Framework

9.2.1. Key Country Dynamics

9.2.2. Competitive Scenario

9.2.3. Regulatory Framework

9.2.4. Target Disease Prevalence

9.3. North America

9.3.1. North America DNA Sequencing Market, 2021 - 2033 (USD Million)

9.3.2. U.S. DNA Sequencing Market, 2021 - 2033 (USD Million)

9.3.3. Canada DNA Sequencing Market, 2021 - 2033 (USD Million)

9.3.4. Mexico DNA Sequencing Market, 2021 - 2033 (USD Million)

9.4. Europe

9.4.1. Europe DNA Sequencing Market, 2021 - 2033 (USD Million)

9.4.2. Germany DNA Sequencing Market, 2021 - 2033 (USD Million)

9.4.3. UK DNA Sequencing Market, 2021 - 2033 (USD Million)

9.4.4. France DNA Sequencing Market, 2021 - 2033 (USD Million)

9.4.5. Italy DNA Sequencing Market, 2021 - 2033 (USD Million)

9.4.6. Spain DNA Sequencing Market, 2021 - 2033 (USD Million)

9.4.7. Denmark DNA Sequencing Market, 2021 - 2033 (USD Million)

9.4.8. Sweden DNA Sequencing Market, 2021 - 2033 (USD Million)

9.4.9. Norway DNA Sequencing Market, 2021 - 2033 (USD Million)

9.5. Asia Pacific

9.5.1. Asia Pacific DNA Sequencing Market, 2021 - 2033 (USD Million)

9.5.2. Japan DNA Sequencing Market, 2021 - 2033 (USD Million)

9.5.3. China DNA Sequencing Market, 2021 - 2033 (USD Million)

9.5.4. India DNA Sequencing Market, 2021 - 2033 (USD Million)

9.5.5. South Korea DNA Sequencing Market, 2021 - 2033 (USD Million)

9.5.6. Australia DNA Sequencing Market, 2021 - 2033 (USD Million)

9.5.7. Thailand DNA Sequencing Market, 2021 - 2033 (USD Million)

9.6. Latin America

9.6.1. Latin America DNA Sequencing Market, 2021 - 2033 (USD Million)

9.6.2. Brazil DNA Sequencing Market, 2021 - 2033 (USD Million)

9.6.3. Argentina DNA Sequencing Market, 2021 - 2033 (USD Million)

9.7. Middle East and Africa

9.7.1. Middle East and Africa DNA Sequencing Market, 2021 - 2033 (USD Million)

9.7.2. South Africa DNA Sequencing Market, 2021 - 2033 (USD Million)

9.7.3. Saudi Arabia DNA Sequencing Market, 2021 - 2033 (USD Million)

9.7.4. UAE DNA Sequencing Market, 2021 - 2033 (USD Million)

9.7.5. Kuwait DNA Sequencing Market, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

10.1. Company Categorization

10.2. Strategy Mapping

10.3. Company Market/Position Share Analysis, 2025

10.4. Company Profiles/Listing

10.4.1. Company Overview

10.4.2. Financial Performance

10.4.3. Product & Service Benchmarking

10.4.4. Strategic Initiatives

10.5. Companies Profiled

10.5.1. Thermo Fisher Scientific, Inc.

10.5.2. Agilent Technology

10.5.3. Illumina, Inc.

10.5.4. QIAGEN

10.5.5. F. Hoffmann-La Roche Ltd.

10.5.6. Oxford Nanopore Technologies plc.

10.5.7. Macrogen, Inc.

10.5.8. PerkinElmer Genomics

10.5.9. PacBio

10.5.10. BGI

10.5.11. Bio-Rad Laboratories, Inc.

10.5.12. Myriad Genetics

10.5.13. PierianDx

10.5.14. Partek Incorporated

10.5.15. Eurofins Scientific

List of Tables [152]

List of Figures [80]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/bq1h0r

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.